Neurocrine Biosciences | 운영 비용

Operating Expenses 변화 날짜
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
Dynavax Technologies USD 64.09M 311K 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Halozyme Therapeutics USD 129M 1.25M 2023-12
Incyte USD 826.07M 121.75M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Repligen USD 169.31M 32.92M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Neurocrine Biosciences 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.